Skip to main content
SpringerLink
Log in

Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Di Stasio F, et al. Corticobasal syndrome: neuroimaging and neurophysiological advances. Eur J Neurol. 2019;26(5):701-e52. https://doi.org/10.1111/ene.13928.

    Article  PubMed  Google Scholar 

  2. Armstrong MJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503. https://doi.org/10.1212/wnl.0b013e31827f0fd1.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Alexander SK, et al. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 2014;85(8):925–9. https://doi.org/10.1136/jnnp-2013-307035.

    Article  CAS  PubMed  Google Scholar 

  4. Ali F, Josephs KA. Corticobasal degeneration: key emerging issues. J Neurol. 2018;265(2):439–45. https://doi.org/10.1007/s00415-017-8644-3.

    Article  CAS  PubMed  Google Scholar 

  5. Hsu J-L, et al. The Imaging features and clinical associations of a novel tau PET tracer-18F-APN1607 in Alzheimer disease. Clin Nucl Med. 2020;45(10):747–56. https://doi.org/10.1097/rlu.0000000000003164.

    Article  PubMed  Google Scholar 

  6. Jia C, et al. Complementary utility of dopamine transporter and tau PET imaging in the diagnosis of progressive supranuclear palsy: a case report. Clin Nucl Med. 2022;47(4):336–8. https://doi.org/10.1097/rlu.0000000000003974.

    Article  PubMed  Google Scholar 

  7. Lu J, et al. Associations of [F]-APN-1607 tau PET binding in the brain of Alzheimer’s disease patients with cognition and glucose metabolism. Front Neurosci. 2020;14:604. https://doi.org/10.3389/fnins.2020.00604.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kikuchi A, et al. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology. 2016;87(22):2309–16. https://doi.org/10.1212/wnl.0000000000003375.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cassinelli Petersen G, et al. Overview of tau PET molecular imaging. Curr Opin Neurol. 2022;35(2):230–9. https://doi.org/10.1097/wco.0000000000001035.

    Article  PubMed  Google Scholar 

  10. Holland N, et al. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study. Brain. 2022;145(1):340–8. https://doi.org/10.1093/brain/awab282.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was financially supported by the National Natural Science Foundation of China (grant number: 81771874) and the CAMS Innovation Fund for Medical Sciences (grant number: CAMS-2021-I2M-1-025).

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, DongchengDistrict, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, WangfujingBeijing, 100730, China

    Menglin Liang, Chenhao Jia & Ruixue Cui

  2. Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

    Menglin Liang, Chenhao Jia & Ruixue Cui

  3. APRINOIA Therapeutics Co, Ltd, Suzhou, China

    Tzu-Chen Yen

  4. Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Linwen Liu

  5. Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Mingli Li

Authors
  1. Menglin Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chenhao Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tzu-Chen Yen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Linwen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mingli Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruixue Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruixue Cui.

Ethics declarations

Ethics approval

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Conflict of interest

The authors declare that they have no competing interests. Tzu-Chen Yen is an employee and shareholder of APRINOIA Therapeutics Co, Ltd, Suzhou, China, and the precursor was provided by APRINOIA Therapeutics Co, Ltd.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Image of the month.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, M., Jia, C., Yen, TC. et al. Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration. Eur J Nucl Med Mol Imaging 49, 4286–4288 (2022). https://doi.org/10.1007/s00259-022-05859-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-022-05859-w

Search

Navigation